drugset / Trial / NCT02592161

Clinical Study of Efficacy and Safety of Chung A Won in Women's Patients With Osteoporosis

NCT02592161 ↗

Phase 2 Completed 166 enrolled Korea Health Industry Development Institute
RandomizedParallel-groupTriple-blindTreatment

Summary

A randomized, single center, double blind, parallel, placebo-controlled, clinical study of efficacy and safety of Chung A Won and placebo for 24 weeks three times a day on the improvement of osteoporosis and symptoms in Women's older than 50 patients with osteoporosis.

Timeline

Start
2012-04
Primary completion
2013-11
Completion
2013-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Chung A Won Unknown 3 g Oral

Indications